rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Charles River Laboratories International, Inc.

CRL · NYSE

Health CareLife-science toolsLeading

CRL stood above a rising 150-day average in 35 of the last 52 weekly readings, including each of the last 17 weeks. It is 34.7% above that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
17 in a row
Industry in uptrend
52% +4 in 4 wk
Insider buys, 12 months
$12K
Insider sales, 12 months
$85.5M
Officials’ trades on record
20
Institutions holding
535 (+11)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 35 of 52 weeks.

17 Apr – 16 Oct
26%41%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$49.6M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

20 disclosed lines: House 20, Senate 0, executive 0; 9 people.

WhoDidAmountTraded
Robert P. Bresnahan, Jr. House: U.S. House ClerkPA08sold$1k–$15k15 May 2025filed 31 May 2025
Jefferson Shreve House: U.S. House ClerkIN06sold$15k–$50k12 May 2025filed 22 Jun 2025
Jefferson Shreve House: U.S. House ClerkIN06bought$15k–$50k8 May 2025filed 22 Jun 2025
Robert P. Bresnahan, Jr. House: U.S. House ClerkPA08bought$15k–$50k8 Apr 2025filed 8 May 2025
Julie Johnson House: U.S. House ClerkTX32boughtjoint$1k–$15k15 Jan 2025filed 12 Feb 2025
Lois Frankel House: U.S. House ClerkFL22sold$1k–$15k8 Sep 2023filed 10 Oct 2023
Lois Frankel House: U.S. House ClerkFL22bought$1k–$15k25 Apr 2023filed 19 May 2023
Zoe Lofgren House: U.S. House ClerkCA19soldspouse$1k–$15k25 Aug 2022filed 13 Sep 2022
Zoe Lofgren House: U.S. House ClerkCA19boughtspouse$1k–$15k30 Sep 2021filed 7 Oct 2021
Susie Lee House: U.S. House ClerkNV03sold$1k–$15k8 Oct 2019filed 5 Dec 2019
Susie Lee House: U.S. House ClerkNV03sold$1k–$15k7 Oct 2019filed 5 Dec 2019
Susie Lee House: U.S. House ClerkNV03bought$1k–$15k29 Aug 2019filed 30 Sep 2019

Insiders

Buy orders, 12 months2
Sale orders, 12 months11
Buyers · sellers2 · 6
WhoDidSharesTraded
Shannon M. ParisottoCEVP, Disc & Safety Assessmentsold981at $308.445 Oct 2026filed 7 Oct 2026
Glenn ColemanEVP & Chief Financial Officerbought10at $297.4330 Sep 2026filed 2 Oct 2026
James C. FosterDirectorsold33,561at $300.0025 Aug 2026filed 27 Aug 2026
Shannon M. ParisottoCEVP, Disc & Safety Assessmentsold2,039at $294.1219 Aug 2026filed 20 Aug 2026
Nancy C. AndrewsDirectorsold573at $285.2418 Aug 2026filed 20 Aug 2026
Shannon M. ParisottoCEVP, Disc & Safety Assessmentsold3,714at $279.6611 Aug 2026filed 13 Aug 2026
Birgit GirshickChief Executive Officersold6,500at $279.9011 Aug 2026filed 13 Aug 2026
James C. FosterDirectorsold28,733at $275.0010 Aug 2026filed 11 Aug 2026
Victoria L. CreamerEVP & Chief People Officersold4,179at $259.166 Aug 2026filed 10 Aug 2026
Michael Gunnar KnellSVP, Finance and CAOsold1,274at $259.076 Aug 2026filed 10 Aug 2026
Michael Gunnar KnellSVP, Finance and CAOsold901at $260.636 Aug 2026filed 10 Aug 2026
Michael Gunnar KnellSVP, Finance and CAOsold810at $261.456 Aug 2026filed 10 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders535+11 on the quarter
New · exited77 · 67
Reported value$12.3B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCadded · filed 13 Aug 20264,239,752$961.5M+783,508+22.7%
BlackRock, Inc.reduced · filed 7 Aug 20263,798,560$861.5M-60,540−1.6%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20263,149,288$714.2M-52,916−1.7%
Invesco Ltd.added · filed 14 Aug 20262,984,785$676.9M+587,533+24.5%
HARRIS ASSOCIATES L Padded · filed 14 Aug 20262,241,144$508.3M+87,848+4.1%
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 20262,210,979$501.4M-83,691−3.6%
Allspring Global Investments Holdings, LLCreduced · filed 13 Aug 20261,905,247$436.5M-88,069−4.4%
STATE STREET CORPreduced · filed 7 Aug 20261,864,284$422.8M-9,334−0.5%
DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 20261,648,450$373.8M-4,034−0.2%
ARIEL INVESTMENTS, LLCadded · filed 14 Aug 20261,506,185$341.6M+62,002+4.3%
31 Mar 2023 – 30 Jun 2026
472532592Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Shannon M. Parisotto Company insiderCEVP, Disc & Safety Assessment · last 5 Oct 20260 · 8
Glenn Coleman Company insiderEVP & Chief Financial Officer · last 30 Sep 20261 · 0
James C. Foster Company insiderDirector · last 25 Aug 20267 · 183
Birgit Girshick Company insiderChief Executive Officer · last 19 Aug 20262 · 17
Nancy C. Andrews Company insiderDirector · last 18 Aug 20260 · 1
Joseph W. LaPlume Company insiderEVP, Corp Strategy & Develop · last 10 Aug 20261 · 27
Michael Gunnar Knell Company insiderSVP, Finance and CAO · last 6 Aug 20260 · 10
Victoria L. Creamer Company insiderEVP & Chief People Officer · last 6 Aug 20260 · 4
Steven Barg Company insiderDirector · last 2 Jun 20260 · 0
Mark Mintz Company insiderEVP, Chief Information Officer · last 31 May 20260 · 0
Abraham Ceesay Company insiderDirector · last 8 May 20260 · 0
Craig B. Thompson Company insiderDirector · last 8 May 20260 · 0

Same industry

OABI OmniAbLeading+65%
TXG 10x GenomicsLeading+60%
AVTR AvantorLeading+47%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+37%
MASS 908 DevicesLeading+31%

Distance from each stock’s own 150-day average.

From its SEC filings

Operating profit marginFY 2025 · to 27 Dec 20250.6%
Free cash flow marginFY 2025 · to 27 Dec 202512.9%
Return on capital employedFY 2025 · to 27 Dec 20250.4%
Debt to equityFY 2025 · to 27 Dec 20250.00×
Share count trendFY 2025 · to 24 Jan 20260.0%
Cash and equivalentsFY 2025 · to 27 Dec 2025$213.8M
Free cash flowFY 2025 · to 27 Dec 2025$518.5M

Analyst forecasts

No analyst forecasts yet.